{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1259073050", "close" : "1259096450", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
businesswire

Mead Johnson Webcasts Investor Meeting


  • Press Release
  • Source: Mead Johnson Nutrition Company
  • On 12:51 pm EST, Friday November 6, 2009

GLENVIEW, Ill.--(BUSINESS WIRE)--Mead Johnson Nutrition Company (NYSE: MJN - News) will host a conference for analysts and investors on Wednesday, Nov. 11, 2009. Members of the company’s senior management team will make presentations beginning at 9 a.m. CST and concluding at 12:30 p.m.

Related Quotes

SymbolPriceChange
MJN44.55-0.29
Chart for MEAD JOHNSON NUTRITI
{"s" : "mjn","k" : "c10,l10,p20,t10","o" : "","j" : ""}

The program will be broadcast live over the Internet. To access the broadcast, go to meadjohnson.com and click on the Investors tab. A replay of the program will be available on the Website after 3:00 CST that same day.

About Mead Johnson

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in 50 markets worldwide. The company’s mission is to create nutritional brands and products trusted to give infants and children the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company’s “Enfa” family of brands, including Enfamil® infant formula, is the world’s leading brand franchise in pediatric nutrition. For more information, go to meadjohnson.com.

Contact:

Mead Johnson Nutrition Company
Investors:
Kathryn Chieger, 847-832-2419
kathryn.chieger@mjn.com
or
Media:
Christopher Perille, 847-832-2178
chris.perille@mjn.com

Sponsored Links

Copyright © 2009 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials by posting, archiving in a public web site or database, or redistribution in a computer network is strictly forbidden.